Analysis of hereditary angioedema attacks requiring a second dose of ecallantide

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 3, 2013, Pages 168-172

  Li, H Henry ^a   Campion, Marilyn ^b   Craig, Timothy J ^c   Soteres, Daniel F ^d   Riedl, Marc ^e   Lumry, William R ^f   Macginnitie, Andrew J ^g   Shea, Elizabeth P ^h   Bernstein, Jonathan A ⁱ  

^a Institute for Asthma and Allergy   (United States)

^b Statistical Consultant   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d Asthma & Allergy Associates PC and Research Center   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f AARA Research Center   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h Dyax Corp   (United States)

ⁱ UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; ECALLANTIDE; ICATIBANT; PLACEBO;

ABDOMINAL ATTACK; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; INJECTION SITE IRRITATION; INJECTION SITE PAIN; INJECTION SITE REACTION; LARYNGEAL ATTACK; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NAUSEA; PERIPHERAL ATTACK; PHASE 3 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT RESPONSE; XEROSTOMIA;

ADULT; ANGIOEDEMAS, HEREDITARY; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE PROGRESSION; DRUG DOSAGE CALCULATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875230696     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.12.004     Document Type: Article

References (25)

1. H. Longhurst, and M. Cicardi Hereditary angio-oedema Lancet 379 2012 474 481
2. B.L. Zuraw Clinical practice: hereditary angioedema N Engl J Med 359 2008 1027 1036
3. K. Bork, G. Meng, P. Staubach, and J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
4. M. Cicardi, K. Bork, T. Caballero HAWK (Hereditary Angioedema International Working Group) Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group Allergy 67 2012 147 157
5. M.M. Frank, and H. Jiang New therapies for hereditary angioedema: disease outlook changes dramatically J Allergy Clin Immunol 121 2008 272 280
6. M. Riedl, M. Campion, P.T. Horn, and W.E. Pullman Response time for ecallantide treatment of acute hereditary angioedema attacks Ann Allergy Asthma Immunol 105 2010 430 436
7. A.L. Sheffer, M. Campion, R.J. Levy, H.H. Li, P.T. Horn, and W.E. Pullman Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies J Allergy Clin Immunol 128 2011 153 159
8. M.K. Vernon, A.M. Rentz, K.W. Wyrwich, M.V. White, and A. Grienenberger Psychometric validation of two patient-reported outcome measures to asses symptom severity and changes in symptoms in hereditary angioedema Qual Life Res 18 2009 929 939
9. M. Cicardi, R.J. Levy, and D.L. McNeil Ecallantide for the treatment of acute attacks in hereditary angioedema N Engl J Med 363 2010 523 531
10. R.J. Levy, W.R. Lumry, and D.L. McNeil EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 523 529
11. L.E. Stolz, and A.L. Sheffer Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema Expert Rev Clin Immunol 8 2012 25 32
12. A.J. Macginnitie, M. Campion, L.E. Stolz, and W.E. Pullman Ecallantide for treatment of acute hereditary angioedema attacks: Analysis of efficacy by patient characteristics Allergy Asthma Proc 33 2012 178 185
13. L. Schneider, W. Lumry, A. Vegh, A.H. Williams, and T. Schmalbach Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor J Allergy Clin Immunol 120 2007 416 422
14. T.J. Craig, R.J. Levy, and R.L. Wasserman Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks J Allergy Clin Immunol 124 2009 801 808
15. T.J. Craig, A.K. Bewtra, and S.L. Bahna C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks-final results of the I.M.P.A.C.T.2 study Allergy 66 2011 1604 1611
16. B.L. Zuraw, P.J. Busse, and M. White Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema N Engl J Med 363 2010 513 522
17. M.A. Riedl, D.S. Hurewitz, R. Levy, P.J. Busse, D. Fitts, and I. Kalfus Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial Ann Allergy Asthma Immunol 108 2012 49 53
18. M. Cicardi, A. Banerji, and F. Bracho Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema N Engl J Med 363 2010 532 541
19. W.R. Lumry, H.H. Li, and R.J. Levy Randomized placebo-controlled trial of the bradykinin B receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial Ann Allergy Asthma Immunol 107 2011 529 537
20. H.J. Longhurst Management of acute attacks of hereditary angioedema: potential role of icatibant Vasc Health Risk Manag 6 2010 795 802
21. I. Boccon-Gibod, and L. Bouillet Safety and efficacy of icatibant self-administration for acute hereditary angioedema Clin Exp Immunol 168 2012 303 307
22. K. Bork, and S.E. Barnstedt Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema Arch Intern Med 161 2001 714 718
23. K. Bork, G. Meng, P. Staubach, and J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784
24. K. Bork, P. Staubach, and J. Hardt Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema Allergy 63 2008 751 757
25. A.T. Waytes, F.S. Rosen, and M.M. Frank Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate N Engl J Med 334 1996 1630 1634